title: Chemoradiotherapy followed by surgery versus surgery alone in esophageal cancer patients: is it time for additional evidence?
abstract: Recent efforts to improve survival in patients with locally advanced esophageal carcinoma have combined both systemic and local therapy. However, the role of neoadjuvant chemoradiotherapy in technically operable IIa-III esophageal carcinoma is still unresolved.
authors.forename: Stefano
authors.initials: S
authors.lastname: Cafarotti
authors.forename: Alfredo
authors.initials: A
authors.lastname: Cesario
authors.forename: Venanzio
authors.initials: V
authors.lastname: Porziella
authors.forename: Stefano
authors.initials: S
authors.lastname: Margaritora
authors.forename: Pierluigi
authors.initials: P
authors.lastname: Granone
mesh_terms: D000970:Antineoplastic Agents / Q000627:therapeutic use; D004938:Esophageal Neoplasms / Q000175:diagnosis* / Q000628:therapy*; D016629:Esophagectomy; D006801:Humans; D008197:Lymph Node Excision; D020360:Neoadjuvant Therapy; D009367:Neoplasm Staging; D018714:Radiotherapy, Adjuvant
chemical_list: D000970:Antineoplastic Agents